Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cevenfacta 1mg (45,000units) inj vials
0211000Z0BCAAAL
|
Cevenfacta | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Cevenfacta 2mg (90,000units) inj vials
0211000Z0BCABAM
|
Cevenfacta | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Cevenfacta 5mg (225,000units) inj vials
0211000Z0BCACAN
|
Cevenfacta | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 120,000unit inj vials
0211000Z0AAABAB
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 1mg (50,000unit) inj pfs
0211000Z0AAAHAH
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 1mg (50,000unit) inj vials
0211000Z0AAADAD
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 240,000unit inj vials
0211000Z0AAACAC
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj pfs
0211000Z0AAAIAI
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 2mg (100,000unit) inj vials
0211000Z0AAAEAE
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj pfs
0211000Z0AAAJAJ
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 5mg (250,000unit) inj vials
0211000Z0AAAFAF
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 60,000unit inj vials
0211000Z0AAAAAA
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj pfs
0211000Z0AAAKAK
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog alfa (activated) 8mg (400,000unit) inj vials
0211000Z0AAAGAG
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 1mg (45,000unit) inj vials
0211000Z0AAALAL
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 2mg (90,000unit) inj vials
0211000Z0AAAMAM
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
Eptacog beta (activated) 5mg (225,000unit) inj vials
0211000Z0AAANAN
|
Factor VIIa | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 120,000unit inj vials
0211000Z0BBABAB
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 1mg (50,000units) inj pfs
0211000Z0BBAHAH
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 1mg (50,000units) inj vials
0211000Z0BBADAD
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 240,000unit inj vials
0211000Z0BBACAC
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 2mg (100,000units) inj pfs
0211000Z0BBAIAI
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 2mg (100,000units) inj vials
0211000Z0BBAEAE
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 5mg (250,000units) inj pfs
0211000Z0BBAJAJ
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
|
NovoSeven 5mg (250,000units) inj vials
0211000Z0BBAFAF
|
NovoSeven | Factor VIIa (Recombinant) | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.